Sex differences in the disposition of albendazole metabolites in sheep

被引:19
作者
Cristofol, C [1 ]
Navarro, M
Franquelo, C
Valladares, JE
Arboix, M
机构
[1] UAB, Fac Vet, Dept Farmacol & Terapeut, Bellaterra 08193, Spain
[2] UAB, Dept Anat & Embriol, Fac Vet, Bellaterra 08193, Spain
关键词
albendazole; sheep-metabolism; sex differences; pharmacokinetics; protein-binding;
D O I
10.1016/S0304-4017(98)00141-1
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Sex differences in the disposition of albendazole metabolites in sheep after oral administration of 20 mg/kg of netobimin have been studied. Some kinetic parameters of both metabolites show statistical differences between sexes; the sulphoxide and sulphone t(1/2 beta) and MRT were lower in male animals than in females. Peak concentrations and AUC of sulphone metabolites were higher in males suggesting a greater oxidation rate compared with females. Urine excretion of albendazole metabolites, sulphoxide, sulphone, and amino sulphone appeared to be greater in female sheep than in males, mainly the sulphoxide metabolite. These differences between sexes can be caused by male sexual hormones, because testosterone and progesterone can induce or inhibit the microsomal Cytochrome P450 metabolism. Plasma protein-binding of albendazole sulphoxide and albendazole sulphone has been studied between male and female sheep, also their binding to sheep albumin and globulins. Both albendazole metabolites readily bind to sheep albumin and globulins. Male animals show a significantly lower binding of albendazole metabolites than females. These differences could be responsible for the non-esterified fatty acids (NEFA) present in the plasma. Males have significantly higher plasma levels of NEFA than females and which may compete with albumin for binding to albendazole metabolites. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 22 条
[1]  
ARBOIX M, 1994, BR J CLIN PHARM, V18, P475
[2]  
ARREDONDO G, 1995, INT J CLIN PHARM TH, V33, P449
[3]  
BOUGEROL T, 1990, Encephale, V16, P35
[4]   GENDER-RELATED DIFFERENCES IN THE AMOUNT AND FUNCTIONAL-STATE OF RAT-LIVER UDP-GLUCURONOSYLTRANSFERASE [J].
CATANIA, VA ;
DANNENBERG, AJ ;
LUQUITA, MG ;
POZZI, EJS ;
TUCKER, JK ;
YANG, EK ;
MOTTINO, AD .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) :509-514
[5]   Comparative pharmacokinetics of netobimin metabolites in pregnant ewes [J].
Cristofol, C ;
Franquelo, C ;
Navarro, M ;
Carretero, A ;
Ruberte, J ;
Arboix, M .
RESEARCH IN VETERINARY SCIENCE, 1997, 62 (02) :117-120
[6]  
Delatour P., 1986, Drug residues in animals, P175
[7]   NETOBIMIN (TOTABIN-SCH) - PRELIMINARY INVESTIGATIONS ON METABOLISM AND PHARMACOLOGY [J].
DELATOUR, P ;
CURE, MC ;
BENOIT, E ;
GARNIER, F .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1986, 9 (02) :230-234
[8]   HEPATIC-MICROSOMAL METABOLISM OF THE POTENTIAL MEMORY-ENHANCING AGENT, CL-275,838, TO ITS DESBENZYL DERIVATIVE [J].
FERRARESE, A ;
DEPALMA, F ;
CELESTE, S ;
MARINI, PP ;
CACCIA, S .
XENOBIOTICA, 1993, 23 (09) :1007-1016
[9]  
GYURIK RJ, 1981, DRUG METAB DISPOS, V9, P503
[10]   THE DISPOSITION OF ALBENDAZOLE IN SHEEP [J].
HENNESSY, DR ;
STEEL, JW ;
LACEY, E ;
EAGLESON, GK ;
PRICHARD, RK .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1989, 12 (04) :421-429